List of insiders holdings for Protagonist Therapeutics Inc:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
JOHNSON & JOHNSON Johnson & Johnson Innovation - JJDC Inc. 10% Owner | 2023-01-11 13:00:18 | 2,449,183 0 | 2,449,183 | Form 13G |
LV Management Group LLC Lilly Ventures Fund I LLC Torres S. Edward Hall Steven Edward 10% Owner | 2020-06-08 16:04:49 | 1,559,060 0 | 1,559,060 | Form 13D |
ADAGE CAPITAL PARTNERS GP L.L.C. Adage Capital Partners L.P. Adage Capital Advisors L.L.C. Atchinson Robert Gross Phillip 10% Owner | 2024-02-07 07:41:40 | 1,291,701 0 | 1,291,701 | Form 13G |
CANAAN X L.P. Canaan Partners X LLC 10% Owner | 2019-01-24 13:09:04 | 1,077,832 0 | 1,077,832 | Form 13G |
PATEL DINESH V PH D President and CEO | 2024-06-17 16:30:17 | 514,415 0 | 514,415 | Form 4 |
Gupta Suneel Chief Development Officer | 2024-02-28 20:00:24 | 183,285 0 | 183,285 | Form 4 |
Liu David Y Chief R&D Strategy Officer | 2022-11-17 18:24:16 | 167,590 0 | 167,590 | Form 4 |
Ali Asif Chief Financial Officer | 2024-09-13 16:35:19 | 157,210 0 | 157,210 | Form 4 |
Saks Samuel R Chief Medical Officer | 2021-02-26 18:35:22 | 104,000 0 | 104,000 | Form 4 |
Shames Richard S. Chief Medical Officer | 2019-03-04 18:29:44 | 83,021 0 | 83,021 | Form 4 |
HODDER WILLIAM A Sr. VP - Corporate Development | 2016-10-13 16:24:06 | 65,000 0 | 65,000 | Form 4 |
Kalkofen Donald A. Chief Financial Officer | 2022-02-17 19:26:56 | 63,521 0 | 63,521 | Form 4 |
MOLINA ARTURO MD Chief Medical Officer | 2024-01-18 20:00:41 | 48,350 0 | 48,350 | Form 4 |
Swisher Daniel N JR Director | 2023-10-30 16:31:33 | 45,000 0 | 45,000 | Form 4 |
O'Neil Thomas P. Chief Financial Officer | 2018-08-17 20:29:55 | 44,610 0 | 44,610 | Form 4 |
Noonberg Sarah B. Director | 2023-01-18 20:03:40 | 30,000 0 | 30,000 | Form 4 |
SELICK HAROLD E Director | 2024-03-11 20:00:28 | 27,996 0 | 27,996 | Form 4 |
Giraudo Bryan Director | 2024-01-04 20:10:25 | 25,700 0 | 25,700 | Form 4 |
Williams Lewis T Director | 2024-01-04 20:14:20 | 25,700 0 | 25,700 | Form 4 |
O'Dowd Sarah A Director | 2024-01-04 20:17:02 | 25,700 0 | 25,700 | Form 4 |
Murphy Niall VP, Controller, Interim PAO | 2019-01-14 20:29:46 | 25,000 0 | 25,000 | Form 3 |
Shanafelt Armen Director 10% Owner | 2018-06-12 18:50:17 | 12,000 0 | 12,000 | Form 4 |
Papanek Julie Director | 2017-05-26 17:27:17 | 12,000 0 | 12,000 | Form 4 |
Waddill William D. Director | 2024-09-12 19:38:43 | 12,000 0 | 12,000 | Form 4 |
KHOSLA CHAITAN PHD Director | 2020-08-12 17:38:37 | 7,499 0 | 7,499 | Form 4 |